Dishman Carbogen Amcis Stock Sees 7.19% Increase, Outperforms Sector and Sensex

Dishman Carbogen Amcis, a smallcap pharmaceutical company, saw a 7.19% increase in its stock price on August 21, 2024. This outperformed the sector by 6.46%, indicating a positive trend for the company. The stock had previously fallen for two consecutive days, but has now gained momentum.

On the same day, the stock reached an intraday high of Rs 184.7, a 7.6% increase from the previous day's close. The stock's moving averages are currently higher than the 5-day, 20-day, and 50-day averages, but lower than the 100-day and 200-day averages.

In comparison to the Sensex, Dishman Carbogen Amcis had a 1-day performance of 8.62%, while the Sensex only had a 0.01% performance. Over the past month, the company's stock has seen a 15.63% increase, while the Sensex has only seen a 0.26% increase.

MarketsMOJO has given a 'Strong Sell' call for Dishman Carbogen Amcis, indicating that investors should be cautious when considering this stock. However, it is important to note that this is a fact-based analysis and does not include any external opinions or recommendations.

Overall, Dishman Carbogen Amcis has shown positive performance in the past day and month, outperforming the sector and the Sensex. Investors should continue to monitor the stock's performance and make informed decisions based on their own research and analysis.